Perivascular Delivery of Rapamycin in Pluronic Gel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury Model, and the Complementary Role of Carotid Arteriography
Authors:
Open Access
- 1 January 2008
- journal article
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 38 (2) , 80-86
Abstract
Jung MJ, et al. Korean Circ J. 2008 Feb;38(2):80-86. http://dx.doi.org/10.4070/kcj.2008.38.2.80Keywords
This publication has 28 references indexed in Scilit:
- Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine modelJournal of Vascular Surgery, 2005
- Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(-caprolactone) stent cuffBiomaterials, 2005
- Sirolimus-Eluting Stents to Abolish Intimal Hyperplasia and Improve Flow in Porcine Arteriovenous GraftsCirculation, 2005
- Potent Inhibitory Effect of Sirolimus on Circulating Vascular Progenitor CellsCirculation, 2005
- A meta‐analysis of clinical trials of paclitaxel‐ and sirolimus‐eluting stents in patients with obstructive coronary artery diseaseBritish Journal of Clinical Pharmacology, 2004
- Local application of rapamycin inhibits neointimal hyperplasia in experimental vein graftsThe Annals of Thoracic Surgery, 2004
- Novel Oral Formulation of Paclitaxel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury ModelCirculation, 2004
- Current Status of Intravascular Stents as Delivery Devices to Prevent RestenosisVascular and Endovascular Surgery, 2003
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993